Actively Recruiting
A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China
Led by Creative Biosciences (Guangzhou) Co., Ltd. · Updated on 2025-02-13
482
Participants Needed
1
Research Sites
164 weeks
Total Duration
On this page
Sponsors
C
Creative Biosciences (Guangzhou) Co., Ltd.
Lead Sponsor
G
Guangzhou Xiangkang Medical Research Co., Ltd.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objective of this study is to assess the safety and effectiveness of Human Multigene Methylation Detection Kit (Fluorescent PCR Method) for help diagnose bladder cancer by comparing with clinical standard method (includes medical imaging (MRI, CT, etc.), cystoscopy, pathological examination).
CONDITIONS
Official Title
A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China
Who Can Participate
Eligibility Criteria
You may qualify if you...
-
Subject must meet all three of the following criteria to be eligible for the study:
-
Who without age and gender limit, and is participating voluntarily and willing to sign Informed Consent Form;
-
Who is willing to undergo or has completed medical imaging and/or cystoscopy and/or pathological examination;
-
Any subject who is required to meet any of the following conditions:
- Who is diagnosed with or suspected of bladder cancer.
- Who has high risk factors for bladder cancer (such as engaged in contact with aromatic amines, dyes, rubber, aluminum, leather and other occupations, schistosomiasis infection, family genetic history, smoking, drinking, etc.).
- Who has hematuria symptoms (such as cystitis, stones, etc.).
- Who has other diseases that can be easily confused with bladder cancer.
-
You will not qualify if you...
-
Subject with any of the following conditions shall be excluded:
- Who has undergone surgery or chemoradiotherapy.
- Who has other conditions that the investigator considers inappropriate to participate in this clinical trial.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Actively Recruiting
Research Team
X
Xianshu Wang, PhD
CONTACT
C
Chunhua Chen
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here